Exact Sciences Q4 Loss of $0.21 Beats Revenue Estimates at $878M
Exact Sciences posted a Q4 adjusted loss of $0.21 per share, widened from a $0.06 loss a year earlier and missing breakeven estimates by a staggering margin. The company generated $878.4 million in revenue, up from $713.4 million and beating consensus by 2.07%.
1. Q4 Financial Results
Exact Sciences recorded an adjusted loss of $0.21 per share in Q4, compared with a $0.06 loss a year earlier and missing the breakeven mark by a substantial margin, marking an 8,300% negative earnings surprise.
2. Revenue Performance
The company posted $878.38 million in Q4 revenue, a 23% increase from $713.42 million a year ago, surpassing consensus estimates by 2.07% and extending its streak of four consecutive quarterly revenue beats.
3. Historical EPS and Revenue Trends
Over the past four quarters, the firm exceeded EPS projections three times and revenue estimates four times, highlighting consistent top-line strength despite recent bottom-line volatility.
4. Market Reaction and Outlook
Shares have risen 1.6% year to date against a 0.2% S&P 500 decline, while analysts forecast $0.14 EPS and $840.62 million revenue for the next quarter, leaving upside dependent on upcoming estimate revisions.